WR
Wolfe Research Latest Price Targets & Analyst Ratings
| Stock | Analyst | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|---|
51
DoorDash
DASH
$106B
|
SK
Shweta Khajuria
| $248.78 | $220 |
12%
downside
| Outperform | 8 months ago |
|
52
Alphabet (Google) Class A
GOOGL
$2.81T
|
SK
Shweta Khajuria
| $232.30 | $230 |
1%
downside
| Outperform | 8 months ago |
|
53
Meta Platforms (Facebook)
META
$1.88T
|
SK
Shweta Khajuria
| $748.65 | $730 |
2%
downside
| Outperform | 8 months ago |
|
54
Magnite
MGNI
$3.54B
|
SK
Shweta Khajuria
| $24.85 | $19 |
24%
downside
| Outperform | 8 months ago |
|
55
Trade Desk
TTD
$25.4B
|
SK
Shweta Khajuria
| $51.92 | $155 |
199%
upside
| Outperform | 8 months ago |
|
56
Uber
UBER
$192B
|
SK
Shweta Khajuria
| $91.98 | $92 |
0%
upside
| Outperform | 8 months ago |
|
|
TEM
57
Tempus AI, Inc. Class A Common Stock
TEM
$13.6B
|
DS
Doug Schenkel
| $78.12 | $60 |
23%
downside
| Outperform | 8 months ago |
|
58
Twist Bioscience
TWST
$1.55B
|
DS
Doug Schenkel
| $25.63 | $60 |
134%
upside
| Outperform | 8 months ago |
|
59
Stevanato
STVN
$6.29B
|
DS
Doug Schenkel
| $23.04 | $28 |
22%
upside
| Outperform | 8 months ago |
|
60
PayPal
PYPL
$65.4B
|
DP
Darrin Peller
| $68.46 | $107 |
56%
upside
| Outperform | 8 months ago |
|
61
Blackstone Mortgage Trust
BXMT
$3.39B
|
KC
Keegan Carl
| $19.78 | $20 |
1%
upside
| Outperform | 8 months ago |
|
62
Pentair
PNR
$18B
|
NC
Nigel Coe
| $110.06 | $125 |
14%
upside
| Outperform | 9 months ago |
|
63
SPX Corp
SPXC
$9.22B
|
BH
Brad Hewitt
| $186.63 | $199 |
7%
upside
| Outperform | 9 months ago |
|
64
Jones Lang LaSalle
JLL
$14.6B
|
AR
Andrew Rosivach
| $307.68 | $353 |
15%
upside
| Outperform | 9 months ago |
|
65
Regeneron Pharmaceuticals
REGN
$60.1B
|
AH
Alexandria Hammond
| $567.22 | $1,150 |
103%
upside
| Outperform | 9 months ago |
|
66
Pfizer
PFE
$140B
|
AH
Alexandria Hammond
| $24.54 | $25 |
2%
upside
| Underperform | 9 months ago |
|
67
Moderna
MRNA
$9.45B
|
AH
Alexandria Hammond
| $24.28 | $40 |
65%
upside
| Underperform | 9 months ago |
|
68
Eli Lilly
LLY
$666B
|
AH
Alexandria Hammond
| $742.91 | $1,000 |
35%
upside
| Outperform | 9 months ago |
|
69
Johnson & Johnson
JNJ
$431B
|
AH
Alexandria Hammond
| $178.76 | $190 |
6%
upside
| Outperform | 9 months ago |
|
70
Gilead Sciences
GILD
$140B
|
AH
Alexandria Hammond
| $112.77 | $110 |
2%
downside
| Outperform | 9 months ago |
|
71
BioMarin Pharmaceuticals
BMRN
$10.9B
|
AT
Akash Tewari
| $56.75 | $95 |
67%
upside
| Outperform | 9 months ago |
|
72
AbbVie
ABBV
$376B
|
AH
Alexandria Hammond
| $213 | $205 |
4%
downside
| Outperform | 9 months ago |
|
73
argenx
ARGX
$44.9B
|
AC
Andy Chen
| $733.66 | $697 |
5%
downside
| Outperform | 9 months ago |
|
74
Danaher
DHR
$143B
|
DS
Doug Schenkel
| $199.03 | $285 |
43%
upside
| Outperform | 10 months ago |
|
|
SARO
75
StandardAero, Inc.
SARO
$9.19B
|
MW
Myles Walton
| $27.48 | $34 |
24%
upside
| Outperform | 10 months ago |
|